Development of a standardized evaluation of endobuccal adverse events induced by repeated tongue protrusion with both a dedicated questionnaire and an endobuccal examination

Cécile Catella, Jean-Arthur Micoulaud-Franchi, Pierre-Jean Monteyrol, Emmanuel Cuny, Olivier M. Vanderveken, Emmanuel d’Incau, Pierre Philip
Eur Arch Otorhinolaryngol. 2019-01-28; :
DOI: 10.1007/s00405-019-05298-8

PubMed
Lire sur PubMed



1. Eur Arch Otorhinolaryngol. 2019 Jan 28. doi: 10.1007/s00405-019-05298-8.

Development of a standardized evaluation of endobuccal adverse events induced by repeated tongue protrusion with both a dedicated questionnaire and an endobuccal examination.

Catella C(1), Micoulaud-Franchi JA(2)(3)(4), Monteyrol PJ(5), Cuny E(6), Vanderveken OM(7)(8)(9), d’Incau E(1)(10), Philip P(5)(11)(12).

Author information:
(1)UFR des Sciences Odontologiques, Université de Bordeaux, Bordeaux, France.
(2)Clinique du Sommeil, CHU Pellegrin, Place Amélie-Raba-Léon, 33076, Bordeaux, France. moc.l1563334424iamg@1563334424dualu1563334424ocim.1563334424ruhtr1563334424aj1563334424.
(3)Univ. Bordeaux, SANPSY, USR 3413, 33000, Bordeaux, France. moc.l1563334424iamg@1563334424dualu1563334424ocim.1563334424ruhtr1563334424aj1563334424.
(4)CNRS-SANPSY, USR 3413, 33000, Bordeaux, France. moc.l1563334424iamg@1563334424dualu1563334424ocim.1563334424ruhtr1563334424aj1563334424.
(5)Clinique du Sommeil, CHU Pellegrin, Place Amélie-Raba-Léon, 33076, Bordeaux, France.
(6)Service de Neuro-chirurgie (E.A., E.C.), CHU de Bordeaux, Place Amélie Raba-Léon, Bordeaux, France.
(7)Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
(8)Department ENT, Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium.
(9)Multidisciplinary Sleep Disorders Center, Antwerp University Hospital, Antwerp, Belgium.
(10)Pôle Odontologie et Santé Buccale, CHU de Bordeaux, Bordeaux, France.
(11)Univ. Bordeaux, SANPSY, USR 3413, 33000, Bordeaux, France.
(12)CNRS-SANPSY, USR 3413, 33000, Bordeaux, France.

INTRODUCTION:
A new approach to treat obstructive sleep apnea (OSA) is upper
airway stimulation therapy (UAS). Electrical pulses applied to the hypoglossal
nerve induce tongue protrusion, increase airway patency and decrease the
frequency of apneic and hypopneic events. Thus, the main objective of this study
was to design a standardized evaluation of endobuccal adverse events induced by
repeated tongue protrusion with both a dedicated questionnaire and an endobuccal
examination.

METHOD:
This study has designed the Tongue Adverse Event and Satisfaction
Questionnaire (TAESQ) and an endobuccal examinations divided into an endobuccal
lesion examination (ELE) and an endobuccal risk factor examination (ERFE).
Evaluations were conducted at month 6 post-implantation.

RESULTS:
The study population after implantation of UAS device consisted of ten
Caucasian males with a mean age of 51.9 ± 11.8 years, and a mean BMI of
28.6 ± 3.3. The AHI of the ten participants ranged from 46.7 ± 12.2/h at baseline
to 14.5 ± 8.9/h with the Inspire therapy at the 6-month follow-up. The TAESQ
revealed pain (30%), followed by less tongue sensitivity (20%) and tongue
weakness (10%). The ELE did not reveal any lesions. The ERFE revealed that some
participants had tissue and dental risk factors but not associated to more
adverse events.

CONCLUSION:
The TAESQ, ELE and ERFE have been designed and studied on a small
number of participants. These evaluations could systematically be included in the
care pathway of patients treated by UAS to better investigate tongue discomfort
and tongue lesion for patients treated with this technology.

DOI: 10.1007/s00405-019-05298-8
PMID: 30689040


Auteurs Bordeaux Neurocampus